2、本次权益变动完成后，将导致公司控股股东、实际控制人发生变更。 关于披露权益变动报告书的提示性公告 证券代码：002172 证券简称：澳洋健康 公告编号：2025-31 江苏澳洋健康产业股份有限公司 关于披露权益变动报告书的提示性公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 特别提示： 1、本次权益变动方式涉及股份协议转让和表决权放弃，不触及要约收购， 亦不构成关联交易。 3、本次权益变动事项尚需有权国资监管机构批准，尚需取得深圳证券交易 所的合规性确认意见，并在中国证券登记结算公司深圳分公司办理股份过户登 记手续。该事项能否最终实施完成及实施结果尚存在不确定性，敬请投资者注 意投资风险。 江苏澳洋健康产业股份有限公司（以下简称"澳洋健康"）于 2025 年 9 月 15 日接到公司控股股东澳洋集团有限公司（以下简称"澳洋集团"）、实际控 制人沈学如及其一致行动人沈卿出具的《简式权益变动报告书》，张家港悦升科 技合伙企业（有限合伙）（以下简称"悦升科技"）出具的《详式权益变动报告 书》，具体情况如下： 一、本次权益变动基本情况 2025 ...

每经AI快讯，9月15日，澳洋健康（002172）(002172.SZ)公告称，公司控股股东澳洋集团与张家港悦升 科技合伙企业(有限合伙)签署了《股份转让协议》，澳洋集团拟将其持有的公司20%股份转让给悦升科 技，转让价格为3.87元/股，交易价款合计为5.93亿元。本次协议转让完成后，悦升科技将成为公司控股 股东，张家港经济技术开发区管委会将成为公司实际控制人。公司股票将于2025年9月16日上午开市起 复牌。 ...

格隆汇9月15日丨澳洋健康(002172.SZ)公布，公司控股股东澳洋集团与张家港悦升科技合伙企业（有限 合伙）（简称"悦升科技"）签署了《股份转让协议》，澳洋集团拟将其持有的公司20%股份共计 153,146,472股，以协议转让方式转让给悦升科技。本次股份转让价格为3.87元/股，股份转让的交易价 款合计为人民币592,676,846.64元。本次协议转让完成后，澳洋集团和沈学如先生不再是公司控股股东 及实际控制人，公司控股股东将变更为悦升科技，张家港经济技术开发区管委会将成为公司实际控制 人。公司股票自2025年9月16日（星期二）上午开市起复牌。 ...

格隆汇9月15日丨澳洋健康(002172.SZ)公布，公司控股股东澳洋集团与张家港悦升科技合伙企业（有限 合伙）（简称"悦升科技"）签署了《股份转让协议》，澳洋集团拟将其持有的公司20%股份共计 153,146,472股，以协议转让方式转让给悦升科技。本次股份转让价格为3.87元/股，股份转让的交易价 款合计为人民币592,676,846.64元。本次协议转让完成后，澳洋集团和沈学如先生不再是公司控股股东 及实际控制人，公司控股股东将变更为悦升科技，张家港经济技术开发区管委会将成为公司实际控制 人。公司股票自2025年9月16日（星期二）上午开市起复牌。 ...

财务顾问 东吴证券股份有限公司 关于 江苏澳洋健康产业股份有限公司 详式权益变动报告书 之 财务顾问核查意见 一、本财务顾问依据的有关资料由信息披露义务人提供。信息披露义务人 已向本财务顾问作出承诺，保证其所提供的一切信息包括书面材料、文件或口 头证言资料等均具有真实性、准确性、完整性和及时性。 二、本财务顾问已按照规定履行了尽职调查义务，对信息披露义务人披露 的《江苏澳洋健康产业股份有限公司详式权益变动报告书》进行了核查，确信 披露文件内容与格式符合规定，并有充分理由确信所发表的专业意见与信息披 露义务人披露的文件内容不存在实质性差异。 三、本财务顾问特别提醒投资者注意，本财务顾问核查意见不构成对本次 权益变动相关各方及其关联公司的任何投资建议，投资者根据本财务顾问核查 意见所做出的任何投资决策而产生的相应风险，本财务顾问不承担任何责任。 四、本财务顾问就《江苏澳洋健康产业股份有限公司详式权益变动报告书》 所发表的核查意见是独立进行的，未委托或授权任何其他机构或个人提供未在 本财务顾问核查意见中列载的信息和对本核查意见做任何解释或者说明。 五、本财务顾问特别提醒本次交易相关主体及投资者认真阅读信息披露义 务 ...

Group 1 - Aoyang Group is planning to transfer the controlling stake of its listed company Aoyang Health, which may lead to a change in actual control [1][4] - Aoyang Group was established in 1998 and has over 30 subsidiaries and more than 5,000 employees, focusing on health, green ecology, and textile industries [3][4] - The company has undergone significant transformations, including the sale of its viscose business to a leading industry player and a shift towards the health industry [4][5] Group 2 - Aoyang Health's stock was suspended from trading starting September 9, with an expected suspension period of no more than two trading days [1] - The identity of the potential buyer for Aoyang Health's controlling stake remains uncertain, with speculation about possible related parties [6] - Aoyang Group has previously reduced its stake in Aoyang Shunchang, now known as Weilan Lithium, through multiple transactions, leading to a decrease in its controlling position [5]

Group 1 - Tianpu Co., Ltd. experienced a significant stock price increase of 185.29% from August 22 to September 10, leading to a halt for further investigation due to abnormal trading [4] - Baiyin Nonferrous Metals has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure [5] - Qingshan Paper Industry confirmed that its production and operational activities are normal, with no significant changes in daily operations [6] Group 2 - Aoyang Health announced that its stock will continue to be suspended due to ongoing negotiations regarding a share transfer by its controlling shareholder [7] - ST Jinke will implement a capital reserve transfer to increase share capital, resulting in a one-day stock suspension [8] - ST Haofeng's stock will resume trading on September 11 after a share transfer agreement was signed, making Zhixin Network the controlling shareholder [9] Group 3 - Fushun Special Steel's stock will be suspended for one day due to a tender offer for shares by Ningbo Meishan Free Trade Port Zone Jincheng Shazhou Equity Investment Co., Ltd. [10] - Fuliwang's subsidiary plans to invest 500 million yuan in a high-end wire material research and production project [11] - ST Tianmao's application for voluntary delisting has been accepted by the Shenzhen Stock Exchange [12] Group 4 - Dongyangguang plans to jointly increase capital in a subsidiary for the acquisition of Qinhuai Data China [13] - Betta Pharmaceuticals intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [14] - Longzi Co., Ltd. plans to acquire a 67.5% stake in Chongqing Time for approximately 92.475 million yuan [15] Group 5 - Dongfang Guoxin plans to establish a joint venture for a technology company with Shunyi Jin Kong [16] - ST Lianshi signed a pre-restructuring investment agreement with selected investors [18] - Shaanxi Construction Group won four construction projects worth over 5 billion yuan in August [19] Group 6 - Dema Technology won a smart logistics project with a well-known Latin American e-commerce giant, valued at approximately 290 million yuan [20] - Mongolian Grass Ecology's subsidiary led a consortium to win a 225 million yuan ecological restoration project [21] - Dajin Heavy Industry signed a long-term production agreement for offshore wind power foundations, with a total value of about 1.25 billion yuan [24] Group 7 - Zhendong Medical's controlling shareholder plans to transfer 5% of the company's shares [25] - ST Hezhong's controlling shareholder is under bail pending trial, but company operations remain unaffected [26] - BYD's senior management and core personnel collectively increased their holdings by approximately 52.33 million yuan [27] Group 8 - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.94% [28] - Sichuan Road and Bridge's controlling shareholder plans to reduce its stake by up to 2% [30] - Lanke Technology's shareholders plan to reduce their holdings by up to 2% [31]

Core Viewpoint - Aoyang Health (stock code: 002172) announced that its stock will continue to be suspended from trading starting September 11, 2025, with an expected suspension period of no more than three trading days [1] Company Summary - Aoyang Health's stock will remain suspended from trading for a maximum of three trading days [1]

Regulatory Actions - Baiyin Nonferrous Metals has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure laws [3] - ST Haofeng announced that Zhixin Network will become the controlling shareholder after a share transfer agreement, with shares resuming trading on September 11, 2025 [7] - Fushun Special Steel will suspend trading for one day due to a share buyback offer, with a total of 9.865 million shares being offered at a price of 5.6 yuan per share [8] Operational Updates - Qingshan Paper Industry reported that its production and operational activities are normal, with no significant changes in daily operations [4] - Aoyang Health announced that its stock will continue to be suspended due to ongoing negotiations regarding a share transfer, with an expected suspension period of no more than three trading days [5] - ST Jinke will implement a capital reserve transfer to increase share capital, leading to a one-day trading suspension [6] Major Contracts and Projects - Shaanxi Construction Group won four construction projects each exceeding 500 million yuan in August, including a 2.4 billion yuan project for a solar hydrogen production facility [11] - Demar Technology secured a 2.9 billion yuan contract for an intelligent logistics project with a well-known e-commerce giant in Latin America [13] - Mongolian Grass Ecology's subsidiary led a consortium that won a 2.25 billion yuan project for ecological protection and restoration in Inner Mongolia [14] - Sanfeng Environment signed a contract worth approximately 2.6 billion Macanese Patacas for waste management services in Macau, with a contract duration of 10 years [15] Shareholding Changes - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.94% through market transactions [17] - Sichuan Road and Bridge's controlling shareholder intends to reduce its stake by up to 2% through block trades [18] - Hexing Co., Ltd. announced that its controlling shareholder plans to reduce its stake by up to 3% through various trading methods [19] - Jingfang Technology's shareholder terminated its share reduction plan without executing any sales during the period [20]

Group 1 - The core point of the article is that Aoyang Health (002172.SZ) is in active negotiations regarding an overall transaction plan, but has not yet signed a formal agreement [1] - The company anticipates that it will not be able to resume trading on September 11, 2025, at the market opening [1] - Aoyang Health has applied to the Shenzhen Stock Exchange for an extension of its stock suspension, which is expected to last no more than three trading days [1]